Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Palantir (PLTR) reported $2.87B revenue in FY2024, up 29% YoY. US commercial revenue +54%. Market cap ~$250B. 3,800+ employees. Denver, CO. AIP (AI Platform) driving accelerating growth. S&P 500 member.
Palantir Technologies builds AI-powered software platforms for government agencies and commercial enterprises. Founded in 2003 by Peter Thiel and Alex Karp, the company initially focused on intelligence and defense applications before expanding to commercial markets.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.